About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
581
By Phase
PHASE3: 1PHASE2: 2
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06858579Lead Sponsor
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
PHASE3Recruiting
480 participants
Started: Feb 10, 2025 · Completed: Dec 31, 2030
NCT06537999Lead Sponsor
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
PHASE2Recruiting
36 participants
Started: Sep 17, 2024 · Completed: Mar 31, 2028
NCT06282159Lead Sponsor
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
PHASE2Active, not recruiting
65 participants
Started: Feb 23, 2024 · Completed: Aug 31, 2027
Locations (1)
Headquarters
Waltham, MA, United States
Map
Loading map...